Trends in MDMA‐related mortality across four countries-Reference-Cited by-同舟云学术

Trends in MDMA‐related mortality across four countries

Published:2021-04-15 Issue:11 Volume:116 Page:3094-3103
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Roxburgh Amanda¹²³^ORCID,Sam Bulent⁴,Kriikku Pirkko⁵⁶,Mounteney Jane⁷^ORCID,Castanera Antonio⁸,Dias Mario⁸⁹,Giraudon Isabelle⁷¹⁰

Affiliation:

1. Behaviours and Health Risks Program Burnet Institute Melbourne Australia

2. Discipline of Addiction Medicine, the Central Clinical School, Sydney Medical School, the Faculty of Medicine and Health University of Sydney Sydney Australia

3. National Drug and Alcohol Research Centre UNSW Sydney Australia

4. Member of the Council of Mortality Related Cases, the Council of Forensic Medicine of Ministry of Justice Turkey

5. Forensic Toxicology Unit Finnish Institute for Health and Welfare Helsinki Finland

6. Department of Forensic Medicine University of Helsinki Helsinki Finland

7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Lisbon Portugal

8. Serviço de Quimica e Toxicologia Forenses do Instituto Nacional de Medicina Legal e Ciências Forenses Lisboa Portugal

9. Laboratório de Ciências Forenses e Psicológicas Egas Moniz Almada Portugal

10. University NOVA and National School of Public Health Lisbon Portugal

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15493

Reference45 articles.

1. United Nations Office on Drugs and Crime (UNODC).World Drug Report 2020. Geneva: UNODC;2020.

2. PeacockA. KarlssonA. UporovaJ. GibbsD. SwantonR. KellyG.et al.Australian Drug Trends 2019: Key Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney UNSW: National Drug and Alcohol Research Centre UNSW;2019.

3. Substance Abuse and Mental Health Services Administration (SAMHSA).Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville MD: Center for Behavioral Health Statistics and Quality SAMHSA;2019.

4. Australian Institute of Health and Welfare (AIHW).National Drug Strategy Household Survey 2019. Canberra: AIHW;2020.

5. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).EMCDDA Statistical Bulletin 2020. Lisbon Portugal: EMCDDA;2020.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature;Pharmaceutics;2024-08-20

2. Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence;Psychedelic Medicine;2024-07-03

3. A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand;Harm Reduction Journal;2024-05-23

4. Developing strategic foresight for drug policy: trends, scenarios, and implications;Drugs: Education, Prevention and Policy;2024-03-25

5. Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand;Harm Reduction Journal;2024-03-21